Dr. Golbarg Esfahani
Pharm. Technology & Biopharmacy
Room 159
Kurt-Mothes-Straße 3,
Tel. +49 345 55 25 134
E-Mail: golbarg.esfahani@pharmazie.uni-halle.de
Publications
1.Esfahani G, Trutschel ML, Reichert D, Mäder K. Characterization of Controlled Release Starch-Nimodipine Implant for Antispasmodic and Neuroprotective Therapies in the Brain. MolecularPharmaceutics. 2023 Sep 26.
2.Esfahani G, Lucas H, Syrowatka F, Mäder K. A starch-based implant as a controlled drug releasesystem: Non-invasive in vivo characterization using multispectral fluorescence imaging. Journalof Controlled Release. 2023 Jun 1;358:358-67.
3.Esfahani G, Häusler O, Mäder K. Controlled release starch-lipid implant for the therapy of severemalaria. International Journal of Pharmaceutics. 2022 Jun 25;622:121879.
4. Salimi A, Makhmalzadeh BS,Esfahani G. Polymeric micelle as a new carrier in Oral drug deliverysystems. Asian J. Pharm. 2017 Oct 1;11(4):704-11.
5. Sharif Makhmal Zadeh B, Niro H, Rahim F,Esfahani G.Ocular delivery system for propranololhydrochloride based on nanostructured lipid carrier. Scientia pharmaceutica. 2018;86(2):16.
6. Sharif Makhmal Zadeh B,Esfahani G, Salimi A. Permeability of ciprofloxacin-loaded polymericmicelles including ginsenoside as P- glycoprotein inhibitor through a Caco-2 cells monolayer asan intestinal absorption model. Molecules. 2018 Jul 31;23(8):1904.
7. Makhmalzadeh BS, Salimi A, Nazarian A,Esfahani G. Formulation, characterization and in vitro/exvivo evaluation of trolamine salicylate- loaded transfersomes as transdermal drug deliverycarriers. International Journal of Pharmaceutical Sciences and Research. 2018 Sep 1;9(9):3725-31.